Thus, PD-1 expression is confined to a fully mature/terminally differentiated NKG2A−KIR+CD57+ subpopulation in CMV-seropositive healthy subjects [66], but not in patients with Kaposi sarcoma [30]. Here, PDCD1 is linked to Kaposi's sarcoma.